Delivery Order SPE2DB22D2218-SPE2DB25FR2NU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,524.91 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on June 25, 2025, with completion targeted for June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a contract ceiling value of $2,250.48. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,085.02 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Exforge 10-160 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by May 7, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Exforge 5-320 mg tablets (30-count units) with a ceiling value of $11,807.90. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,768.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 10-320 mg on July 14, 2025, with completion expected by July 15, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,588.62 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count units). This firm fixed price delivery order, with an ultimate completion date of June 3, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,007.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 5-320 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Exforge 10-160 mg tablets (30-count units) with a ceiling value of $4,993.49. This firm fixed-price delivery order, which is not set-aside and will be completed by July 24, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR2NUDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) with a ceiling value of $1,117.93. This firm fixed price delivery order, awarded on May 15, 2025, represents a non-set-aside competitive award with an ultimate completion date of May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a critical vendor within the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical commodities to support military healthcare programs and other federal healthcare systems. The company's pharmaceutical portfolio under this vehicle encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, demonstrating its role as a primary vendor for federal defense medical logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/15/25 |